Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP (1548)
My previous session
Most popular
  Report  
End-of-day quote. End-of-day quote  - 12/14
11.84 HKD   -2.63%
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
12/10/2018 12/11/2018 12/12/2018 12/13/2018 12/14/2018 Date
11.72 11.76 11.7 12.16 11.84 Last
6670500 5481850 3661000 5888195 7732205 Volume
-3.30% +0.34% -0.51% +3.93% -2.63% Change
Financials (HKD)
Sales 2018 1 689 M
EBIT 2018 262 M
Net income 2018 261 M
Finance 2018 196 M
Yield 2018 -
Sales 2019 2 045 M
EBIT 2019 319 M
Net income 2019 315 M
Debt 2019 173 M
Yield 2019 -
P/E ratio 2018 80,80
P/E ratio 2019 69,80
EV / Sales2018 13,1x
EV / Sales2019 11,0x
Capitalization 22 293 M
More Financials
Company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
12/04Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
10/05GENSCRIPT BIOTECH : Bio buys back 500,000 shares
AQ
10/03GENSCRIPT BIOTECH : Bio takes legal actions against Flaming Research
AQ
09/28JOHNSON & JOHNSON : Short seller accuses GenScript of CAR T data fraud
AQ
09/27GENSCRIPT BIOTECH : Stock of China's GenScript Plummets on Report Critical of Un..
DJ
09/18GENSCRIPT BIOTECH : Bio inks cancer drug's license & development deal
AQ
08/28GENSCRIPT BIOTECH : Bio 1H net up 3.6% to US$15.5m; no div
AQ
08/17GENSCRIPT BIOTECH : Bio to invest in bio-fermentation products biz
AQ
08/05JOHNSON & JOHNSON : J&J Bets on Chinese Startup That Uses Llama DNA to Fight Can..
DJ
07/05GENSCRIPT BIOTECH : Bio to build manufacturing center in Zhenjiang
AQ
More news
Sector news : Bio Diagnostics & Testing
12/14FDA Approves Herceptin Biosimilar Herzuma
DJ
12/13Lilly, Incyte Get FDA Fast-Track Designation for Baricitinib in Systemic Lupu..
DJ
12/10Almost half of S&P 500 stocks in a bear market
RE
12/10ROCHE : Gilead Sciences snares Roche veteran O'Day as CEO
RE
12/10LONZA : to Establish Biomanufacturing Base in China
DJ
More sector news : Bio Diagnostics & Testing
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 35,3  HKD
Spread / Average Target 190%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP-42.10%2 854
MIRACA HOLDINGS INC.-45.64%1 350
IOVANCE BIOTHERAPEUTICS INC23.88%1 221
CAREDX INC280.25%1 150
INVITAE CORP--.--%930
BEIJING STRONG BIOTECHNOLOGIES INC--.--%766